SAM- and SH3-domain containing 1 (SASH1) inhibit hepatocellular carcinoma invasion and migration by inactivating the HH and PI3K/AKT pathways in vitro and in vivo (47). Here, SASH1 is linked to hepatocellular carcinoma.